|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Prashant Kesharwani, PhD (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India) , Prashant Kesharwani (Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)Publisher: Elsevier Science Publishing Co Inc Imprint: Woodhead Publishing Weight: 1.000kg ISBN: 9780323858816ISBN 10: 0323858813 Pages: 556 Publication Date: 28 September 2022 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of Contents1. Cell-SELEX technology for aptamer selection 2. Biological characteristics of aptamers 3. Mechanisms of multi-drug resistance of cancer 4. Relevance of aptamers as targeting ligands for anticancer therapies 5. Aptamers as smart ligands for nano-carriers cancer targeting 6. Aptamer-functionalized liposomes for targeted cancer therapy 7. Aptamer-functionalized micelles for targeted cancer therapy 8. Aptamer-functionalized nanoparticles for targeted cancer therapy 9. Aptamer-functionalized PLGA nanoparticles for targeted cancer therapy 10. Aptamer-functionalized silica nanoparticles for targeted cancer therapy 11. Aptamer-functionalized gold nanoparticles for targeted cancer therapy 12. Aptamer-functionalized dendrimers for targeted cancer therapy 13. Aptamer-functionalized carbon nanotubes for targeted cancer therapy 14. Aptamer-functionalized quantum dots for targeted cancer therapy 15. Cancer immunotherapy via nucleic acid aptamers 16. Aptamer-based imaging and diagnostics for cancer cells 17. Microdevice-based aptamer sensors 18. Aptamer-based microfluidics for circulating tumor cells 19. Aptamer-based theranostic approaches for treatment of cancer 20. Challenges of aptamers as targeting ligands for anticancer therapies 21. Clinical use and future perspective of aptamersReviewsAuthor InformationDr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award, most prestigious “Ramanujan Fellowship Award. He actively participates in outreach and scientific dissemination for the service of the wider community. Tab Content 6Author Website:Countries AvailableAll regions |